dbo:abstract |
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe. Talipexole is a D2 dopamine receptor agonist and interacts both pre- and post-synaptic receptors. It also is an α2-adrenergic agonist. The main side effects are drowsiness, dizziness, hallucinations and minor gastrointestinal complaints. In 2008 the Japanese Ministry of Health, Labour, and Welfare mandated that Boehringer add a warning to the label concerning the risk of sudden onset of sleep. (en) |
dbo:alternativeName |
Domin (en) |
dbo:casNumber |
101626-70-4 36085-73-1 |
dbo:chEMBL |
1289023 |
dbo:fdaUniiCode |
7AM2J46Z1Y 9R6E1D8H1O |
dbo:pubchem |
5374 |
dbo:thumbnail |
wiki-commons:Special:FilePath/Talipexole.svg?width=300 |
dbo:wikiPageExternalLink |
https://pubchem.ncbi.nlm.nih.gov/compound/134342 |
dbo:wikiPageID |
18485332 (xsd:integer) |
dbo:wikiPageLength |
4756 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1118537725 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Pramipexole dbr:Boehringer_Ingelheim dbc:D2-receptor_agonists dbr:Dopamine_agonist dbc:Allyl_compounds dbc:Alpha-2_adrenergic_receptor_agonists dbr:Thiourea dbr:Management_of_Parkinson's_disease dbr:Allyl_bromide dbc:Azepanes dbc:Thiazoles dbr:Alpha-adrenergic_agonist dbc:Dopamine_agonists dbc:Alpha-1_blockers dbr:Dopamine_receptor_agonist dbr:File:Talipexole_synthesis.svg |
dbp:atcPrefix |
none (en) |
dbp:c |
10 (xsd:integer) |
dbp:casNumber |
101626 (xsd:integer) 36085-73-1 (en) |
dbp:chembl |
1289023 (xsd:integer) |
dbp:chemspiderid |
5181 (xsd:integer) |
dbp:h |
15 (xsd:integer) |
dbp:image |
Talipexole-3D-balls.png (en) |
dbp:index2Label |
DIHYDROCHLORIDE (en) |
dbp:iupacName |
6 (xsd:integer) |
dbp:iupharLigand |
5442 (xsd:integer) |
dbp:legalStatus |
Rx-only (en) |
dbp:n |
3 (xsd:integer) |
dbp:pubchem |
5374 (xsd:integer) |
dbp:routesOfAdministration |
Oral (en) |
dbp:s |
1 (xsd:integer) |
dbp:smiles |
C=CCN1CCC2=CSCN (en) n1c2cCCNC\C=C (en) |
dbp:stdinchi |
1 (xsd:integer) |
dbp:stdinchikey |
DHSSDEDRBUKTQY-UHFFFAOYSA-N (en) |
dbp:synonyms |
Alefexole (en) |
dbp:tradename |
Domin (en) |
dbp:unii |
7 (xsd:integer) 9 (xsd:integer) |
dbp:verifiedfields |
changed (en) |
dbp:verifiedrevid |
414779406 (xsd:integer) |
dbp:watchedfields |
changed (en) |
dbp:wikiPageUsesTemplate |
dbt:Adrenergic_receptor_modulators dbt:Drugbox dbt:Nervous-system-drug-stub dbt:Reflist dbt:Rp dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Ebicite dbt:Fdacite dbt:Stdinchicite dbt:Antiparkinson dbt:Drugs.com dbt:Dopamine_receptor_modulators |
dcterms:subject |
dbc:D2-receptor_agonists dbc:Allyl_compounds dbc:Alpha-2_adrenergic_receptor_agonists dbc:Azepanes dbc:Thiazoles dbc:Dopamine_agonists dbc:Alpha-1_blockers |
gold:hypernym |
dbr:Agonist |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:AliphaticCompound114601294 yago:Alkene114713120 yago:Chemical114806838 yago:Communication100033020 yago:Compound114818238 yago:Formula106816935 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:WikicatAlkenes |
rdfs:comment |
Talipexole (B-HT920, Domnin) is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe. Talipexole is a D2 dopamine receptor agonist and interacts both pre- and post-synaptic receptors. It also is an α2-adrenergic agonist. (en) |
rdfs:label |
Talipexole (en) |
owl:sameAs |
freebase:Talipexole yago-res:Talipexole wikidata:Talipexole dbpedia-fa:Talipexole dbpedia-sh:Talipexole dbpedia-sr:Talipexole https://global.dbpedia.org/id/4vWEv |
prov:wasDerivedFrom |
wikipedia-en:Talipexole?oldid=1118537725&ns=0 |
foaf:depiction |
wiki-commons:Special:FilePath/Talipexole-3D-balls.png wiki-commons:Special:FilePath/Talipexole.svg wiki-commons:Special:FilePath/Talipexole_synthesis.svg |
foaf:isPrimaryTopicOf |
wikipedia-en:Talipexole |
is dbo:wikiPageRedirects of |
dbr:C10H15N3S |
is dbo:wikiPageWikiLink of |
dbr:List_of_adrenergic_drugs dbr:Dopamine_receptor_D2 dbr:C10H15N3S dbr:Alpha-2_adrenergic_receptor dbr:Alpha-adrenergic_agonist dbr:List_of_drugs:_T–Td |
is foaf:primaryTopic of |
wikipedia-en:Talipexole |